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SUMMARY
A screening programme of thyroid disease in 214 elderly patients attending
hospital was undertaken incorporating clinical and biochemical assessment. The
prevalence of untreated hypothyroidism was 2.8%, treated hypothyroidism
2.8%, untreated hyperthyroidism 0.9%, sub-clinical hypothyroidism 4.7%,
and non-thyroidal illness 3.3%. Onepatient with hypopituitarism was identified.
Clinicaljudgement alone waspoor. The costs ofsuch a screeningprogramme are
discussed and the benefits highlighted.
INTRODUCTION
Thyroid disease in the elderly often presents atypically, and the traditional clinical
criteria for diagnosis of both hypothyroidism and hyperthyroidism may be
masked and therefore unhelpful.' As effective treatment is available, routine
screening tests in the elderly of thyroid function have been advocated.2,3
However, considerable debate continues as to the benefit of screening the
healthy elderly living in the community.4-7
The aim of this study was to determine the prevalence of undiagnosed thyroid
disease in all elderly patients presenting to the Geriatric Medical Unit at the Royal
Victoria and Throne Hospitals, Belfast, and to assess the benefits of such a
routine screening programme.
METHOD
New patients aged 65 years and over, referred to the Geriatric Unit between
August 1986 and January 1987 for admission, outpatient and day hospital
attendance, were assessed and screened for the presence of thyroid disease.
A standard proforma was completed for each patient at the first attendance, and
included assessment of weight loss, energy, temperature preference, hair and
skin changes, current medication and previous thyroid treatment. Clinical
examination was carried out with particular reference to the presence or absence
ofsigns ofthyroid disease, including goitre, lid lag and retraction and delay ofthe
tendon reflexes. Judgement was then made regarding the overall clinical
impression of thyroid status and recorded as either hypothyroid, euthyroid or
hyperthyroid.
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Blood was sampled for serum total thyroxine (total T4) and thyroid-stimulating
hormone (TSH) estimation. Serum total T4 was measured by a solid-phase
radioimmunoassay8 and serum TSH measured by radioimmunoassay.9 If initial
results were abnormal, a second sample was sent for repeat total T4 and TSH
estimation. In addition, measurement of thyroid antibody titres, free T4 and
response to thyrotropin-releasing hormone (TRH) were performed as clinically
indicated. The criteria used for a diagnosis of hypothyroidism were total T4
repeatedly less than 50 nmol/l with an accompanying elevation of TSH above
5 mU/I. Hyperthyroidism was diagnosed if the total T4 was greater than
150 nmol/l and accompanied by a diminished TSH response to an intravenous
challenge with 200 pg of TRH.
RESULTS
Two hundred and fourteen subjects (160 females, 53 males) were studied, with
a mean age of 80.6 years, mean total T4 of 82.2 nmol/l and mean TSH of
3.1 mU/I. Normal thyroid function tests were found in 182 patients (85%), of
whom 48 were male (mean age 76.2 years) with a mean total T4 of 82.9 nmol/l
and a mean TSH of 1.6 mU/I, and 134 female (mean age 82.1 years) with a
mean total T4 of 86.3 nmol/l and a mean TSH of 1.8 mU/I. Initial clinical
assessment alone incorrectly judged three of this group as hypothyroid and five
as hyperthyroid. Abnormal thyroid function tests were present in 32 patients
(15%) (Table 1).
TABLE I
Categories ofpatients with abnormal thyroid function results
Mean age
Number (years) Male Female % of total
Untreated hypothyroid 6 79 6 2.8%
Treated hypothyroid 6 88 1 5 2.8%
New hyperthyroid 2 72 1 1 0.9%
Normal total T4 with
raised TSH 10 79.5 1 9 4.7%
Low total T4 with
normal TSH 8 83.3 2 6 3.8%
Untreated hypothyroidism
Six new cases of hypothyroidism were identified (Table 11) with a mean total T4 of
32.9 nmol/l and a mean TSH of 32.8 mU/I. Initial clinical assessment of this
group correctly judged one patient as hypothyroid and th&- remainder were
assessed incorrectly as euthyroid. One patient died from cardiac failure, while the
remainder improved considerably after treatment with resolution of many non -
specific symptoms, accompanied by increased mobility, enabling a return to
continuing independence at home.
Treated hypothyroidism
Six patients (5F, 1M) were identified with a previous history of hypothyroidism
and thyroxine replacement therapy, with a mean total T4 of 90.5 nmol/I and a
mean TSH of 8.0 mU/I. Two of this group were receiving an inadequate dose of
thyroxine and were correctly judged to be clinically hypothyroid.
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Hyperthyroidism
Two patients were found to have elevated total and free T4 levels, flat TSH
response to TRH; they were judged to be hyperthyroid and treated with radio-
active iodine and carbimazole respectively. Neither case was identified on initial
clinical assessment alone.
Normal total T4 with raised TSH
Ten patients had normal levels of total T4 with elevated TSH levels. On repeat
measurement, the level of TSH returned to normal in three patients, while seven
remained abnormal (Table 111). Two of this group had been incorrectly judged
clinically to have hyperthyroidism.
TABLE II
Untreated hypothyroid patients identified by the screening programme
Total T4 TSH Thyroid
Age Sex nmol/l mU/I antibodies Presenting illness
1. 90 F 46 10 Osteoarthritis
2. 75 F 34 20 Chest infection
3. 86 F 22 60 - Cardiac failure
4. 82 F 35 26 Lack of energy
5. 75 F 6.3 25 Arthritis
6. 66 F 48 57 + Myelofibrosis
TABLE Ill
Sub-clinical hypothyroidism: normal total T4 with TSH greater than 5.0 mU/l
on initial screening test
Age! Total T4 TSH
Sex nmol/l mU/l
(initial test)
79
80
78
71
83
F
F
F
F
F
63
59
84
83
60
6.7
5.4
5.9
5.3
8.2
Total T4 TSH
nmol/l mU/l
(second test)
60
72
60
70
54
5.9
5.4
5.7
3.0*
4.2*
78 F 63 6.1 70 6.6
78 F 61 26.5
78 F 96 5.8
62 16.2
92 2.9*
95 F 80 5.7
75 F 68 8.9 59 7.0
Thyroid
antibodies Presenting illness
Epilepsy
- Cardiac failure
Osteoarthritis,
diabetes mellitus
- Gout
Cerebrovascular
disease
Partial thyroidectomy
for thyrotoxicosis
+ Cerebrovascular
disease
Cerebrovascular
disease
Terminal
bronchopneumonia
+ Pernicious anaemia
*TSH returned to normal on repeat estimation.
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Low total T4 with normal TSH (non-thyroidal illness)
Eight patients (six female and two male; mean age 83.3 years) with lowered
levels oftotal T4 and normal TSH levels were identified. The mean total T4 was 37
nmol/l and TSH 2.1 mU/I. A diagnosis of hypopituitarism was confirmed in one
subject. Five patients were seriously ill and subsequently died, and two were
recovering after operative fixation of femoral neck fracture. Three of this group
were suspected on clinical grounds to have hypothyroidism.
DISCUSSION
Untreated hypothyroidism was detected in 2.8% of the elderly hospital patients,
a figure comparable to that of 2.3% recorded in hospital inpatients,' and higher
than the prevalence rate of 0.94% reported from the elderly in the community.5
The overall prevalence rate of untreated and treated hypothyroidism combined
was 5.6%. Hyperthyroidism was less common with a prevalence rate of 0.9%
in comparison with 0.47% reported from the elderly in the community.5 The
diagnosis ofhypothyroidism on clinical grounds alone was poor, with detection of
only one of the six new hypothyroid patients. That clinical diagnosis alone is
difficult is further supported by the finding that the majority of this group had
attended other hospital departments in the preceding months without detection
of the hypothyroidism. This highlights the non-specific clinical presentation of
hypothyroidism in the elderly' and is an important factor in support of an elective
screening programme of the elderly attending hospital rather than reliance on
clinical diagnosis alone.
One area of concern is that routine screening will reveal the presence ofequivocal
results, with resultant difficulty of interpretation and commitment to long-term
follow-up. Seven patients had repeatedly normal total T4 levels with moderate
elevation of TSH but without clinical evidence of hypothyroidism. This group
may be deemed to have sub-clinical hypothyroidism 10 and will require regular
monitoring of thyroid function to detect progression to overt hypothyroidism at
an early stage. If thyroid antibodies are also present, then the risk in females of
progression to overt hypothyroidism is particularly increased and estimated at
5% per year." A second group of eight subjects were identified with low total
T4 levels and normal TSH level. A diagnosis of hypopituitarism was confirmed
in one patient and appropriate cortisone and thyroxine replacement therapy
commenced, with resolution of confusion and immobility. Five of this second
group were seriously ill and subsequently died. Two were recovering from major
surgery, confirming a relationship with severe illness previously attributed to
lowered protein and thyroxine binding globulin levels and inhibitors of binding.'2
Thus, the majority of elderly patients will fall into one of five distinct categories
whose management is straightforward.
Screening of each elderly hospital patient will have an add-on cost to the
laboratories of approximately £3, with the cost of total T4 measurement approx-
imately £1 and TSH £;2 per sample. Costs may be reduced by screening using
only TSH 13 or total T4 estimation, but neither alone will accurately identify the
3% of the patients with sub-clinical hypothyroidism, a proportion of whom may
benefit from thyroxine therapy.14 The total cost of screening 214 patients was
approximately £650, resulting in expenditure of around £100 to detect each
case of previously undiagnosed hypothyroidism. Treatment costs with thyroxine
replacement are small and we would deem the overall financial cost of such
thyroid function screening to be cost-effective.
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There are considerable variations in the practice of geriatric medicine and
selective procedures for admission throughout the UK, and thus reliance on
prevalence figures from other reported studies may be misleading. This study has
enabled us accurately to establish the prevalence of thyroid disease in the
population ofsick elderly patients presenting to this geriatric medical unit. It is our
belief that the yield of both hypothyroidism and hyperthyroidism previously
undetected is an important and worthwhile task and fullyjustifies screening ofthe
sick elderly. Appropriate treatment has afforded considerable clinical benefit,
symptomatic relief and improvement of the elderly patients' quality of life.
Reliance on clinical diagnosis alone ofthyroid disease in the elderly is inadequate,
with many patients remaining undetected and denied effective treatment. Elective
screening for thyroid disease in the elderly hospital patient is therefore an
important, cost-effective, worthwhile and rewarding task.
We gratefully acknowledge the assistance of Mr Brian Sheridan with the laboratory estimations of T4
and TSH, and the junior medical staff of the Geriatric Medical Unit who performed a large number of
assessments.
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